Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06538662 · ClinicalTrials.gov registry record · Phase 3
An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations
A Phase 3 study, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 283
- Enrollment target
NCT06538662 is a Phase 3 study that has completed, run by Alcon Research. The registered enrollment target is 283 participants.
The verdict
NCT06538662, a Phase 3 study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 283 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the safety and efficacy of FID 123320 Ophthalmic Solution compared to Vehicle for relieving redness of the eye due to minor eye irritations in pediatric and adult populations.
Interventions
- DRUG Vehicle
- DRUG FID 123320 Ophthalmic Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 283 participants |
| Start Date | 2024-10-07 |
| Est. Completion | 2025-04-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06538662
The ClinicalTrials.gov registry entry for NCT06538662 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 283 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT06538662 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06538662 about?
NCT06538662 is a clinical study titled "An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations". The purpose of this study is to assess the safety and efficacy of FID 123320 Ophthalmic Solution compared to Vehicle for relieving redness of the eye due to minor eye irritations in pediatric and adult populations.
What is the current status of trial NCT06538662?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 283 participants. The study started on 2024-10-07. Estimated completion is 2025-04-03.
What interventions are being tested in trial NCT06538662?
The interventions under investigation include: Vehicle (DRUG), FID 123320 Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT06538662?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.